Zoé van Kempen

Research output

Research output per year 2017 2019 2021 2022 2023 2023

• 38 Article
• 5 Comment/Letter to the editor
• 5 Letter
• 2 Meeting Abstract
• 4 More
  • 2 Editorial
  • 1 Review article
  • 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

  Wieske, L., Stalman, E. W., van Dam, P. J. K., Kummer, L. Y., Steenhuis, M., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G., van der Kooi, A., Raaphorst, J., Löwenberg, M., Takkenberg, B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., & 38 othersBosma, A. L., Hilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, Y. K. O., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Keijzer, S., Keijser, J., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., van Ham, S. M., Kuijpers, T. W., Rispens, T. & Eftimov, F., 1 Jun 2023, In: Annals of the Rheumatic Diseases. 82, 6, p. 883-885 3 p., ard-2022-223464.

  Research output: Contribution to journal › Letter › Academic › peer-review
• 2021

  Response to letter ‘Lymphocyte counts and the risk of COVID-19 in people with MS’

  Loonstra, F. C., van Kempen, Z. L. E., Strijbis, E. M., Killestein, J., Hoitsma, E. & Mostert, J. P., Sept 2021, In: Multiple Sclerosis Journal. 27, 10, p. 1626-1627 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

• Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients

  van Kempen, Z. L. E., van Rossum, J. A., Hoogervorst, E., Strijbis, E., Toorop, A., Bosscha, M. I., Frequin, S., Dam-van Loon, N. T., Wattjes, M. P., Murk, J-L., Killestein, J. & Uitdehaag, B. M. J., 1 May 2021, In: Multiple Sclerosis and Related Disorders. 50, 102838.

  Research output: Contribution to journal › Letter › Academic › peer-review
• 2019

  Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation

  van Kempen, Z. L. E., van Rossum, J. A., Doesburg, D., Claessen, I., de Vries, A., ten Brinke, A., van Oosten, B. W., Rispens, T. & Killestein, J., 1 Jul 2019, In: Journal of Neurology. 266, 7, p. 1804-1805 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

• Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy

  Loonstra, F. C., Verberk, I. M. W., Wijburg, M. T., Wattjes, M. P., Teunissen, C. E., van Oosten, B. W., Uitdehaag, B. M. J., Killestein, J. & van Kempen, Z. L. E., 1 Aug 2019, In: Annals of Neurology. 86, 2, p. 322-324 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review